CADL
Candel Therapeutics, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:58 PM EST
5.32USD-1.481%(-0.08)1,389,687
Pre-marketNov 18, 2026 9:26:30 AM EST
5.36USD-0.741%(-0.04)
After-hoursNov 18, 2026 4:00:30 PM EST
5.32USD0.000%(-0.00)
Loading…
Loading…
416.94M
Healthcare
Biotechnology
HQ
Needham, MA, USA
Previous Close
$5.40
Beta
2.20
52-Week High
$14.00 2026-08-27
52-Week Low
$4.35 2025-11-25
SMA 50
$9.33
SMA 200
$8.40
Avg. Vol 10D
2.03M
Avg. Vol 30D
1.40M
Avg. Vol 90D
1.27M
Relative Vol
1.00
78.45M
62.15M
79.22%
13,087,782
21.73%
13.31
54%/46%
49.66%
36.23%
0.6000%
200,000
39,318
15,312
39,318
-99.1M
-1.48
-70.2M
-93.65
Nov 18, 2026
Nov 17, 2026
Nov 16, 2026
CADL Profile
also known as advantagene. inc., we are a massachusetts-based biotechnology company developing our proprietary immuno-oncology platforms for the treatment of solid tumors, including our gene mediated cytotoxic (gmci™) platform and our rqnestin34.5 platform. gmci™ is an "off-the-shelf" immunotherapy designed to generate a personalized, robust, and precise systemic response from the patient's own immune system against his or her cancer.
CADL Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 8.39 | 2026-11-12 | -36.65% | -4.573 |
| 1M | 8.21 | 2026-10-19 | -35.26% | 2.853 |
| 3M | 13.50 | 2026-08-19 | -60.63% | 2.711 |
| 6M | 7.66 | 2026-05-19 | -30.61% | 2.243 |
| 1Y | 4.42 | 2025-11-19 | +20.25% | 2.203 |
| 2Y | 3.99 | 2024-11-19 | +33.21% | — |
| 5Y | 10.87 | 2021-11-19 | -51.10% | 1.234 |
CADL Stock Summary
Candel Therapeutics, Inc. Common Stock (NASDAQ:CADL) stock price today is $5.32, and today's volume is 1,389,687. CADL is down 1.574% today. The 30 day average volume is 1.40M. CADL market cap is $416.94M with 78.45M shares outstanding.